Clinical trial
Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow…
NCT00207792 · Centre National de Greffe de Moelle Osseuse, Other · Unknown status
Key facts
| NCT number | NCT00207792 |
|---|---|
| Title | Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation |
| Official title | Randomized Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation |
| Lead sponsor | Centre National de Greffe de Moelle Osseuse, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Drug |
| Interventions | filgrastim |
| Enrollment | 160 |
| Start date | Jul 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 6, 2007 |
| Countries | Tunisia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: